Executive Brief

  • Cintas Corporation reported fiscal 2026 Q1 results with revenue of $2.72 billion, up 8.7% YoY, driven by 7.8% organic growth and 0.9% acquisitions (Item 2.02, Exhibit 99).
  • Gross margin increased 9.1% to $1.37 billion, with margin rate improving 20 bps to 50.3%.
  • Operating income rose 10.1% to $617.9 million, operating margin at 22.7%.
  • Net income grew 8.7% to $491.1 million; diluted EPS increased 9.1% to $1.20.
  • Effective tax rate was 17.6% in Q1, impacted by discrete items related to stock-based compensation.
  • Share repurchases totaled $347.4 million during Q1 and through September 23, 2025.
  • Quarterly dividend paid September 15, 2025, was $182.3 million, up 15.4% YoY.
  • Fiscal 2026 guidance raised: revenue now $11.06-$11.18 billion (from $11.00-$11.15B), diluted EPS $4.74-$4.86 (from $4.71-$4.85).
  • Guidance assumes no acquisitions, constant FX rates, and interest expense of ~$97 million due to refinancing.
  • Key risk/trigger: interest expense increase from refinancing senior notes; monitoring acquisition activity and share buybacks that may affect interest and EPS.

Item-by-Item Analysis

Item 2.02 – Results of Operations and Financial Condition

  • What happened: Cintas announced fiscal 2026 Q1 results ended August 31, 2025.
  • Revenue: $2.72B, +8.7% YoY; organic growth 7.8%, acquisitions 0.9%.
  • Gross margin: $1.37B, +9.1%; margin rate 50.3% vs. 50.1% prior year.
  • Operating income: $617.9M, +10.1%; margin 22.7% vs. 22.4%.
  • Net income: $491.1M, +8.7%.
  • Diluted EPS: $1.20, +9.1%.
  • Effective tax rate: 17.6%, impacted by discrete tax items related to stock-based compensation.
  • Share repurchases: $347.4M during Q1 and through Sept 23, 2025.
  • Dividend: $182.3M paid Sept 15, 2025, +15.4% YoY.
  • Fiscal 2026 guidance raised:
    • Revenue: $11.06B-$11.18B (prior $11.00B-$11.15B).
    • Diluted EPS: $4.74-$4.86 (prior $4.71-$4.85).
  • Guidance assumptions:
    • No future acquisitions.
    • Constant FX rates.
    • Interest expense ~$97M (vs. $95M prior year), reflecting refinancing senior notes at higher rates partially offset by lower variable rate interest.
  • Source: (Item 2.02), (Exhibit 99, paras 1-24).

Item 9.01 – Financial Statements and Exhibits

  • Exhibits filed:
    • 99: Press release dated September 24, 2025.
    • 104: Inline XBRL cover page.
  • Source: (Item 9.01).

Exhibits Summary

  • Exhibit 99: Press release provides detailed financial metrics, management commentary, and updated guidance.
  • No other agreements or decks attached.

Financial & Dilution Impact

  • Revenue growth of 8.7% driven by organic and acquisition growth.
  • Share repurchases of $347.4 million reduce share count, supporting EPS growth.
  • Dividend increased by 15.4%, reflecting strong cash flow.
  • Interest expense expected to rise slightly due to refinancing senior notes.
  • EPS guidance raised modestly, reflecting operational strength and capital allocation.

Timeline & Required Actions

  • Q1 ended August 31, 2025.
  • Dividend paid September 15, 2025.
  • Report and press release issued September 24, 2025.
  • Guidance updated for full fiscal year 2026.
  • No acquisitions assumed in guidance; future acquisitions or buybacks may affect interest and EPS.

Risks & Monitoring

  • Interest expense increase from refinancing senior notes at higher rates.
  • Impact of discrete tax items on effective tax rate.
  • Potential changes in share buybacks or acquisitions affecting interest expense and EPS.
  • FX rate fluctuations not assumed in guidance but could impact results.

Metadata & Quality Checks

  • No OCR or parsing issues detected.
  • Non-GAAP reconciliation: Unknown (not referenced).
  • Forward-looking statements present in guidance commentary.
  • No conflicts or related-party transactions disclosed.

Final Checklist

  • Items 2.02 and 9.01 identified and analyzed.
  • Press release fully summarized.
  • Financial impacts quantified.
  • Guidance changes noted.
  • Risks and triggers enumerated.
  • Metadata and quality checks completed.

Original Filing